Necroptosis does not drive disease pathogenesis in a mouse infective model of SARS-CoV-2 in vivo

Stefanie M. Bader,James P. Cooney,Reet Bhandari,Liana Mackiewicz,Merle Dayton,Dylan Sheerin,Smitha Rose Georgy,James M. Murphy,Kathryn C. Davidson,Cody C. Allison,Marc Pellegrini,Marcel Doerflinger
DOI: https://doi.org/10.1038/s41419-024-06471-6
2024-01-31
Cell Death and Disease
Abstract:Necroptosis, a type of lytic cell death executed by the pseudokinase Mixed Lineage Kinase Domain-Like (MLKL) has been implicated in the detrimental inflammation caused by SARS-CoV-2 infection. We minimally and extensively passaged a single clinical SARS-CoV-2 isolate to create models of mild and severe disease in mice allowing us to dissect the role of necroptosis in SARS-CoV-2 disease pathogenesis. We infected wild-type and MLKL-deficient mice and found no significant differences in viral loads or lung pathology. In our model of severe COVID-19, MLKL-deficiency did not alter the host response, ameliorate weight loss, diminish systemic pro-inflammatory cytokines levels, or prevent lethality in aged animals. Our in vivo models indicate that necroptosis is dispensable in the pathogenesis of mild and severe COVID-19.
cell biology
What problem does this paper attempt to address?